Forty Cases of Therapy for Mental Retardation Associated with Agitation by Ziprasidone Mesylate
10.3870/yydb.2015.07.015
- VernacularTitle:甲磺酸齐拉西酮治疗精神发育迟滞伴发激越40例
- Author:
Junhui PING
;
Fei PAN
;
Zhaoxi ZHONG
;
Lina WANG
;
Jingdan ZHANG
;
Yonghe CAO
- Publication Type:Journal Article
- Keywords:
Ziprasidone,mesylate;
Haloperidol;
Mental retardation;
Agitation symptoms,acute
- From:
Herald of Medicine
2015;(7):899-902
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy and safety of ziprasidone mesylate injection on the acute agitation symptom in mental retardation. Methods The total of 80 patients of mental retardation with acute agitation symptoms were randomly divided into two groups:the treatment group (40 patients) were intra-muscarly given with ziprasidone mesylate injection at the initial dose of 10 mg, 20 mg 4 h later, and 30 mg once on the second day and third day. And the control group (40 patients) were treated with haloperidol injection. The volume dose of haloperidol was 20 mg everyday. Other antipsychotic drugs, antimanic drugs and benzodiazepines were not allowed to be used during the observation, neither does the prophylactic use of drugs against parkinson's disease. Before and 1, 2, 4, 6, 8, 12, 24, 48, 72 h after treatment, the positive and negative scale ( PANSS) reduction rate, the end of the clinical global impression scale ( CGI) were assessed. By the end of the treatment, the adverse reactions symptom, cale ( TESS) was assessed for the safety. Results By the end of treatment PANSS reduction rate was 46. 31% in the test group and 48. 81% in the control group, the clinical improvement rate was 80. 00% in the treatment group and 82. 50% in the control group. No statistically significant difference on efficacy was found between two groups. The side reaction rate in the treatment group was 27. 5%, that in the control group was 40. 0%, there was significant difference ( P<0. 05) between two groups, but the extrapyramidal reaction in the control group was significantly more than that in the treatment group(P<0. 05). Conclusion Ziprasidone mesylate injection is effective on treating the symptoms of mental retardation, in corresponding to the effect of haloperidol injection,and with less extrapyramidal reactions.
